Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What are the main possible reasons for the rejection of my Wholesale Dealer Licence renewal application for western medicines?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q441 · Category I: Renewals, changes and penalties for non-compliance (Q401-Q450)
Refusal of a renewal application is uncommon but has serious consequences, and usually stems from fundamental compliance issues. The most common reasons include serious breaches during the previous licence period, such as repeated warnings or disciplinary action; major deficiencies identified during the renewal inspection that were not corrected promptly, particularly in the Quality Management System (QMS), medicine traceability or storage conditions; the company or one of its key personnel being convicted of a criminal offence, leading the regulator to consider it no longer a ‘fit and proper’ licence holder; or failure to provide key documents required for the renewal review, such as a valid Business Registration Certificate or SOP documents meeting GDP requirements.

📘 Regulatory basis

When assessing renewal applications, the regulatory authority comprehensively evaluates the licence holder’s compliance throughout the licence period to determine whether it remains suitable to hold the licence.

📗 Drew Tang's recommendations

The best way to avoid renewal refusal is to maintain ongoing compliance in day-to-day operations. Our annual compliance consultancy service for clients is intended to keep their operations inspection-ready through regular reviews and follow-up, and to eliminate renewal risks at source.

📕 Risk notice

If a renewal application is refused, it is equivalent to revocation of the licence and your business must cease immediately. This is not only a major commercial setback; it also means that the compliance credibility you have built up is gone.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗